Trials / Completed
CompletedNCT02643927
Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population
Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population: a Controlled Study
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- Hospital Miguel Servet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to assess and compare the efficacy of a standard 8-weeks protocol based on the Mindfulness Based Stress Reduction MBSR program versus a 4-week shortened version of the protocol in the improvement of wellbeing variables in a non-clinical population in Spain. The investigators initial hypothesis was that both protocols are efficacious but the standard 8-week performs better that the short one.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | standard 8-weeks MBSR | A 8 weekly sessions of 120 min based on the standard protocol of Kabat Zinn was performed. The adapted program did not include a one-day retreat in silence, but one session in silence plus extra kindly awareness (compassion-based) and value-based exercises. Home practice was not systematically assessed, but recommended to be of 45min per day, most of the days. It was administered by a trained (3-y experience) and certified MBSR teacher (MMPD). |
| BEHAVIORAL | 4-week shortened MBSR | This protocol was made up of 4 sessions of 120 mn administered by the same trained MBSR programme therapist to avoid variables associated to the therapist. The rationale behind the shortened version of MBSR was to keep the core content and practices of the program, in fewer sessions: raisin exercise (experiential concept of mindfulness); and main anchors of attention (breathing, body sensations, body movements). |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-04-01
- Completion
- 2013-10-01
- First posted
- 2015-12-31
- Last updated
- 2016-01-01
Source: ClinicalTrials.gov record NCT02643927. Inclusion in this directory is not an endorsement.